Skip to content
Open access

Deciphering the clinical significance of Beclin-1 and Bcl-2 in urothelial carcinoma of bladder

Sep 2026 · Indian Journal of Urology · Vol 42, pp. 287 - 299 · 0 citations · 28 references
Medicine

Abstract

ABSTRACT Background: Considering an important interplay of Beclin-1 and Bcl-2 in autophagy, where Bcl-2 inhibits autophagy by binding and inhibiting Beclin-1, evaluation of their expressions may provide insights into the tumor biology of the clinically distinct non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). Materials and Methods: Beclin-1 and Bcl-2 expressions were examined by real-time quantitative polymerase chain reaction, Western hybridization, and immunohistochemical staining (IHC) in 47 NMIBC and 37 MIBC patients. Their expressions were evaluated in relation to patients’ demographics. Autophagic vesicles (AVs)/autophagy were examined by transmission electron microscopy (TEM). Results: Fold change expressions of Beclin-1 and Bcl-2, at the gene level, were observed to be asymmetrical/skewed. Significances of expressions at the mRNA level with tumor stage (P = 0.0415), grade (P = 0.0488), and size (0.0451) in the NMIBC cohort were observed, whereas Bcl-2 expression exhibited significances with stage (P = 0.0328) and tumor type (P = 0.0499) in NMIBC and MIBC (P = 0.0474) patients. Western blotting and IHC showed decreased Beclin-1 and increased Bcl-2 immunostaining with an increase in the tumor stage and grade. TEM micrographs recorded an increase in AVs/autophagy in a tumor stage and grade-dependent manner. Tumor size was identified as a predictor of short progression-free survival (P = 0.031) in NMIBC patients. The Kaplan–Meier test could not identify Beclin-1 and Bcl-2 as the predictors of survival outcomes. Conclusion: Beclin-1 downregulation, Bcl-2 upregulation, and increased autophagy in tumor stage and grade-dependent manner suggest their role in aggressiveness of the bladder cancer.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.